Research programme: pain therapeutics - Penwest Pharmaceuticals
Alternative Names: Pain therapeutics research programme - Penwest Pharmaceuticals; PW 4102; PW 4104Latest Information Update: 25 Apr 2007
At a glance
- Originator Penwest Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 25 Apr 2007 Discontinued - Preclinical for Pain in USA (unspecified route)
- 21 Oct 2003 Preclinical trials in Pain in USA (unspecified route)